INS and COVID-19: Our pathway enrichment analysis revealed that SARS-CoV-2 had a substantial impact, affecting key pathways such as the oxidative phosphorylation, insulin secretion, estrogen signaling, antigen processing and presentation, and oxytocin pathways relevant to the clinical presentations specific to COVID-19, its pregnancy-related complications, and preeclampsia [12,13].